ENDP: Summary for Endo Pharmaceuticals Holdings I - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 3:00am EST - Canadian Markets open in 6 hours and 30 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Endo Pharmaceuticals Holdings Inc. (ENDP)

On Feb 9: 19.63 USD 0.00 (0.00%)

MORE ON ENDP

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Endo Pharmaceuticals Holdings I (NasdaqNM:ENDP) Delayed quote data

After Hours: 19.53

0.10 (0.51%) as of 8:01pm EST on 02/09/10

Last Trade:	19.63 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	19.63
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	23.59

Day's Range:	N/A - N/A
52wk Range:	15.75 - 24.10
Volume:	0
Avg Vol (3m):	1,472,960
Market Cap:	2.30B
P/E (ttm):	11.65
EPS (ttm):	1.69
Div & Yield:	N/A (N/A%)

Endo Pharmaceuticals Holdings Inc. (ENDP)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add ENDP to Portfolio

Download Data

HEADLINES

•	Dow Jones back over 10,000: How Philadelphia companies are faring
	at bizjournals.com (Tue 2:05pm)

•	Dow Jones down again on Friday: How Phila. is faring
	at bizjournals.com (Fri, Feb 5)

•	Dow Jones thrown for Thursday loss: How Phila. companies are faring
	at bizjournals.com (Thu, Feb 4)

•	Dow Jones, Phila.-area stocks up on home sales news Tuesday
	at bizjournals.com (Tue, Feb 2)

•	[video] Five-Star Stocks
	at TheStreet.com (Sat, Jan 30)

•	Pharma research: Pool of skills and low costs fosters growth
	at FT.com (Thu, Jan 28)

•	Dow Jones down on Thursday: How Philadelphia stocks are faring
	at bizjournals.com (Thu, Jan 28)

•	[video] Stock Wrap: The Real Story, January, 26
	at TheStreet.com (Tue, Jan 26)

•	Bears Target Humana, Medco Options
	at TheStreet.com (Wed, Jan 20)

•	ENDO PHARMACEUTICALS HOLDINGS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
	EDGAR Online (Tue, Jan 19)

More Headlines for ENDP...

ANALYST

EPS Est (next year) (Dec-09) :	2.72
EPS Est (in 2 years) (Dec-10) :	2.84
Avg Rec (current)*:	2.6
PEG Ratio:	0.76

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Endo Pharmaceuticals Holdings Inc., a pharmaceutical company, engages in the research, development, sale, and marketing of branded and generic prescription pharmaceuticals for treating and managing pain primarily in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•